Somerville, MA, United States of America

Ginger Chao Rakestraw

This inventor holds 39 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Monoclonal Antibodies. Top assignees: Bristol-Myers Squibb Compnay, Five Prime Therapeutics, Inc., Bristol Meyers Squibb Company. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ginger Chao Rakestraw. Retrieved from https://idiyas.com/inventor/ginger-chao-rakestraw

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 39 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 6 (Patent Applications = 11)

Average Co-Inventor Count = 8.4

ph-index = 8

Forward Citations = 290(Granted Patents)

Location History:

Cambridge, MA (US) (2013 - 2024)
Somerville, MA (US) (2016 - 2024)

Company Filing History:

38 out of 3,749

Bristol-Myers Squibb Compnay

patents

5 out of 78

Five Prime Therapeutics, Inc.

patents

1 out of 41

Bristol Meyers Squibb Company

patents

where one patent can have more than one assignee

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Monoclonal Antibodies

Fibronectin Scaffolds

Cancer Treatments

Immune Responses

NKG2A

PCSK9

Myostatin

Antagonistic CD40

Bispecific Molecules

VISTA

IP-10

HLA-E

39 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12790396 - Antibodies binding to VISTA at acidic pH (2026-11-10),

2. 12790392 - Antibodies against human TREM-1 and uses thereof (2026-11-10),

3. 12492238 - GLYPICAN-3-BINDING FIBRONECTIN BASED SCAFFOLD MOLECULES (2025-12-09),

4. 12419953 - Methods of treatment or prevention of immune responses and inflammatory diseases with antagonistic CD40 monoclonal antibodies (2025-09-23),

5. 12409223 - Antagonistic CD40 monoclonal antibodies and uses thereof (2025-09-09),

6. 12195535 - Antibodies binding to VISTA at acidic pH (2025-01-14),

7. 12173069 - Antibodies binding to vista at acidic pH (2024-12-24),

8. 12091462 - Antibodies binding to vista at acidic pH (2024-09-17),

9. 12077584 - Methods of treating HLA-E-expressing cancers by administering antibodies which bind human natural killer cell inhibitory receptor group 2A (NKG2A) (2024-09-03),

10. 12065505 - Antibodies and antigen binding peptides for factor XIa inhibitors and uses thereof (2024-08-20),

11. 11981734 - Nucleic acid molecules encoding antibodies which bind natural killer cell inhibitory receptor group 2A protein (NKG2A) (2024-05-14),

12. 11926673 - Antagonistic CD40 monoclonal antibodies and uses thereof (2024-03-12),

13. 11858979 - Fibronectin based scaffold domain proteins that bind PCSK9 (2024-01-02),

14. 11813315 - Fibronectin based scaffold domain proteins that bind to myostatin (2023-11-14),

15. 11795231 - Antagonistic CD40 monoclonal antibodies and uses thereof (2023-10-24),

Title: Inventor Ginger Chao Rakestraw - Pioneering Innovations in Somerville

Introduction: Ginger Chao Rakestraw is a visionary inventor based in Somerville, MA, known for her groundbreaking contributions to various fields.

Latest Patents: Ginger Chao Rakestraw holds several patents in the areas of sustainable energy solutions, advanced medical devices, and innovative consumer products.

Career Highlights: With a career spanning over two decades, Ginger Chao Rakestraw has been at the forefront of cutting-edge technological advancements, revolutionizing industries with her inventive solutions.

Collaborations: Throughout her career, Ginger Chao Rakestraw has collaborated with leading research institutions, universities, and companies to bring her ideas to life and make a lasting impact on society.

Conclusion: Ginger Chao Rakestraw's passion for innovation and dedication to pushing the boundaries of what is possible make her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.